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Identification and Cloning of the SNARE Proteins VAMP-2
and Syntaxin-4 from HL-60 Cells and Human Neutrophils
James E. Smolen,1,4 Ronald J. Hessler,2 William M. Nauseef,3 Melissa Goedken,3 and
Youngson Joe1
Abstract—Degranulation and membrane fusion by neutrophils are essential to host defense. We
sought homologues of neuron-specific fusion proteins in human neutrophils and in their precur-
sors, the promyelocytic cell line HL-60. We screened a differentiated HL-60 library and obtained
an 848 bp sequence with a 351 bp open reading frame, identical to that published for human
VAMP-2 and including 5′ and 3′ untranslated regions. RNA from HL-60 cells during differ-
entiation into the neutrophil lineage was subjected to Northern blot analysis, which revealed a
transcript of ∼1050 bp at all stages of differentiation. The amount of these transcripts increased
approximately threefold during differentiation, a finding confirmed by quantitative RT-PCR. We
also detected mRNA for VAMP-2 in human neutrophils and monocytes using RT-PCR. In like
fashion, transcripts of syntaxin-4, another fusion protein, were recovered from a neutrophil cDNA
library. As with VAMP-2, expression of syntaxin-4 (determined by Northern blots) also increased,
but by only 50%, during differentiation of HL-60 cells. These studies demonstrate that neutrophils
and their progenitors possess mRNA for the fusion proteins VAMP-2 and syntaxin-4, and that their
transcription increases during differentiation, concurrent with the functional maturation of myeloid
cells.
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INTRODUCTION
Exposure of human neutrophils to a variety of partic-
ulate and soluble stimuli evokes a series of responses,
including chemotaxis, phagocytosis, degranulation, hex-
ose monophosphate shunt stimulation, generation of
reactive derivatives of oxygen, release of membrane-
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bound calcium and reorganization of the cytoskleton (1,
2). The most efficient oxygen-dependent microbicidal
system in phagocytes, the myeloperoxidase-H2O2-halide
system, requires concurrent degranulation and oxidase
activation for full potency. Despite its important contri-
bution to microbicidal activity, the least understood of
agonist-dependent neutrophil responses is degranulation
and the associated fusion events that occur between the
granule and plasma or phagosomal membrane. With that
in mind, we focused our attention on the annexin and
nonannexin elements that regulate fusion in neutrophils.
Synaptosomes, endosomes and Golgi are among the
few experimental systems in which in vitro fusion has
been studied under physiological conditions (3–8). In
these systems, several proteins are required at different
stages of the docking and fusion process, with various
factors often being required transiently during the chore-
Smolen, Hessler, Nauseef, Goedken, and Joe256
ography. For example, the final fusion steps generally
involve a protein that is sensitive to N-ethyl maleimide
(designated “NEM-sensitive fusion protein” or NSF),
Soluble NSF-Attachment Proteins (SNAP), ATP, acetyl-
CoA, vesicle associated membrane protein (VAMP),
SNAP-25, syntaxin, synaptotagmin, rabphilin and unc-
18. Taken together, these elements represent components
of the SNARE (SNAP-Receptor) complex.
Because similar fusion events and requirements
have been defined in endosome fractions over a broad
range of species and cell types (9–13), an analogous set
of factors likely regulates fusion in neutrophils. How-
ever, the lack of evidence for NSF-like proteins in neu-
trophils suggests that neutrophils may exploit unique
variations of the neuronal model to achieve the same
effect. Indeed, neutrophil appear to lack the entire “neu-
ronal complement” of fusion proteins, as only SNAP-
25 (14), syntaxin-1 (15), syntaxin-4 and VAMP-2 (16)
have been detected in neutrophils at the protein level.
mRNA transcripts for SNAP-23 have been reported in
HL-60 cells (17). Recently, several forms of syntaxin
were found in neutrophils and HL-60 cells (15) and
we have identified annexin I (18) and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) (19), neither of
which is part of the standard neuronal model, as impor-
tant cytosolic fusion proteins in neutrophils.
Based on these data, we examined expression of
VAMP-2 and syntaxin-4 in HL-60 cells and neutrophils.
cDNA encoding VAMP-2 was isolated from a differ-
entiated HL-60 library and sequenced, as was a partial
sequence for syntaxin-4. Expression of genes encoding
VAMP-2 and syntaxin-4 increased during differentiation
of HL-60 cells. Circulating neutrophils (cells exhibiting
relatively little protein synthesis) and monocytes pro-
duced mRNA for both VAMP-2 and syntaxin-4. Taken
together, our studies extend findings of previous reports
and are the first to show that neutrophils actively produce
mRNA for these SNARE proteins.
MATERIALS AND METHODS
Reagents
Agarose (low melting point) and Dulbecco’s phos-
phate buffered saline were obtained from Gibco (Grand
Island, NY). RNAsin ribonuclease inhibitor, reverse
transcriptase (avian myeloblastosis virus) and EcoRI
were purchased from Promega (Madison, WI). [a-
32P]-dCTP was purchased from New England Nuclear
(Boston, MA). Hybond nylon membranes and Rapid-
Hyb buffer were obtained from Amersham (Arling-
ton Heights, IL). Guanidinium thiocyanate was pur-
chased from Fluka (Switzerland). Mono-Poly Resolving
Medium was purchased from ICN Biomedicals (Aurora
OH). NZCYM agar and NZCYM top agar were pur-
chased from Bio 101, Inc. (Vista, CA). Fast Track
mRNA Isolation Kits and pcDNA3.1 vector were pur-
chased from Invitrogen (Carlsbad, CA). Random Prim-
ing Labelling Kits, pBlueScript II vector, XL1-Blue,
Able C, and Able K were obtained from Stratagene (La
Jolla, CA). The PCR MIMIC Construction Kit was pur-
chased from Clontech (Palo Alto, CA). Taq polymerase
was purchased from Fisher (Pittsburgh, PA). Human
serum albumin was purchased from Alpha Therapeutic
Corporation (Los Angeles, CA).
Cells
Venous blood from normal healthy adult donors
was collected in 10 U/ ml heparin (Elkins-Sinn, Inc.,
Cherry Hill, NJ). Neutrophils were isolated using Ficoll-
Hypaque gradients (Mono-Poly medium, ICN Biomedi-
cals, Aurora, OH) (20). Cells were washed and resus-
pended in Dulbecco’s Phosphate Buffered Saline with-
out Ca2+ or Mg2+ at 48 and pH 7.4, along with 0.1%
human serum albumin. Monocytes were also isolated by
this method and routinely subjected to parallel analyses.
HL-60 cells were grown in RPMI 1640 supple-
mented with 20% fetal calf serum and 1% penicillin–
streptomycin. For studies on differentiated cells, 1.25%
dimethyl sulfoxide (DMSO) was employed, with sam-
ples being taken every day for 4 days.
Libraries
For the majority of this work, a library for differen-
tiated HL-60 cells was employed (21). The mRNA was
derived from HL60 cells grown in 1.25% DMSO for 4
days. Corresponding cDNA was cloned into the EcoRI
site of lambda ZAP. An undifferentiated HL-60 library
in lambda ZAP was the generous gift of Dr. George
Dubyak, Case Western Reserve School of Medicine,
Cleveland, OH. A neutrophil library in the lambda ZAP
Express cloning vector pBK-CMV was generously pro-
vided by Drs. Inder Patel and Ashok Amin, Hospital
for Joint Diseases, New York University Medical Center,
New York, NY. This library was prepared from an atopic
patient and contains other cells, such as eosinophils,
along with activated neutrophils. A human brain library
in lambda ZAP was the generous gift of Dr. A. Zaheer,
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Department of Neurology, University of Iowa School of
Medicine, Iowa City, IA.
Library Screens
The differentiated HL-60 library (a total of 1 × 106
plaque forming units) was employed to screen for cDNA
to VAMP-2. For syntaxin-4, we transformed pBK-CMV
in XL-1 Blue cells and screened a total of 106 colony-
forming units. A radiolabeled probe for VAMP-2 was
prepared using the full-length sequence obtained by PCR
screening of the total HL-60 library cDNA (1061B4B,
vide infra). For syntaxin-4, the probe was a cDNA an
820 nt portion of the coding region of human muscle
syntaxin-4 (a gift from Dr. M. N. Jagadish, Parkville,
Australia) (22). The probes were labeled with [32P] by
random priming (Stratagene, La Jolla, CA), incubated
with the blots (prehybridized and blocked with Rapid-
Hyb Buffer, Amersham) at 658 for 2 h, and then washed
at high stringency (0.2X SSC/ 0.1% SDS). Following
autoradiography, several positive clones were identified
and used for further studies. We conducted secondary,
tertiary, and quaternary screening until we obtained a sin-
gle positive clone.
Northern Blots
Total RNA was obtained from HL-60 cells (∼108
total) that were differentiated with 1.2% DMSO for vary-
ing periods of time (0 to 4 days) and also from iso-
lated neutrophils and monocytes using RNAzol solu-
tion (23). Poly-T-coated beads (Invitrogen, Carlsbad,
CA) were sometimes used to isolate mRNA from these
samples. For the Northern blots, total RNA (20 mg)
or mRNA (4 mg) were subjected to electrophoresis on
1% formaldehyde gels, and then transferred to Hybond
nylon membranes (Amersham). Probe cDNA (obtained
by PCR screening of the HL-60 library as described
under Results) was labeled by random priming, and the
blots were hybridized and washed at high stringency as
described previously. For a positive control, the coding
region of p47phox was also employed (21). As a measure
of loading, a sequence of the coding region of GAPDH
(nucleotides 2-775, obtained with primers G1 and G2,
below) was employed. The developed autoradiographs
were scanned using Corel Photopaint and the intensities
of bands were quantitated with ImageQuant software.
Background subtraction was generally done by “local
average,” according to the software. These intensity val-
ues were then expressed as ratios of VAMP-2/ GAPDH,
syntaxin-4/ GAPDH or p47phox/ GAPDH, normalized to
Day 0 (VAMP-2 or syntaxin-4) or Day 2 (p47phox). In
some cases, intensities of 28S rRNA were used for nor-
malization in place of GAPDH.
Primers for PCR
The primers employed in this work for both PCR
and RT-PCR are given in the following. In some cases,
minor modifications of the neuronal VAMP-2 sequence
were made to avoid hairpins, primer dimers, and primer-
pair interactions.
Primer A 5′-AATCTTACCAGTAACAGGAGA-3′
Upper primer corresponding to bp 71–92 of
coding region of human VAMP-2 (351 bp
total).
Primer B 5′-AGTGCTGAAGTAAACGATGAT-3′
Lower primer corresponding to bp 327–347
of coding region of human VAMP-2 (351
bp total).
Primer C 5′-ATACGAATTCAAACCTCACCAGT-
AACAGGAGA-3′ Same as Primer A,
except for EcoRI site added.
Primer D 5′-ATCCGAATTCAAGTGCTGAAGTA-
AACTATGAT-3′ Same as Primer B,
except for EcoRI site added.
Primer E 5′-TTGGGGCTAGTCAGGAAAGAAA
G-3′ Lower Primer for the full-length clone
designated M40D1. This primer corre-
sponds to bp 665-686 of M40D1 and was
used for sequencing.
Primer F 5′-CAGGCCCAGGTGGATGAGGT-3′
Upper Sequencing Primer for M40D1,
corresponding to bp 134–153 of M40D1
and 105–124 of the coding region.
Primer G1 5′-GATCGAATTCGCCAGCCGAGCC-
ACA TCG-3′ Upper Primer for human
GAPDH, corresponding to nucleotides 2 to
21 of the coding region along with an
EcoRI site at the 5′ end.
Primer G2 5′-GATCGGTACCGGCAGGTCAGGTC-
CAC CACT-3′ Lower Primer for human
GAPDH, corresponding to nucleotides 756
to 775 of the coding region along with a
Kpn-1 site at the 3′ end of the product.
Primer S1 5′-ATGCGCGACAGGACCCACGAG-
CTG-3′ Upper primer corresponding to bp
1–24 of coding region of human syntaxin-4
(894 bp total) (22).
Primer S2 5′-TTATCCAACCACTGTGACGCCAAT-
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GAT-3′ Lower primer correspond-
ing to bp 867–894 of coding region of
human syntaxin-4 (894 bp total) (22).
RT-PCR
Total RNA was isolated as before from human neu-
trophils, monocytes, and HL-60 cells that were differ-
entiated with 1.2% DMSO over a 4-day time course.
Aliquots of total RNA (1 mg) were prepared and incu-
bated with reverse transcriptase according to manufac-
turer’s instructions (Promega). Antisense primers were
Primer D (VAMP-2), Primer S2 (syntaxin-4), or Primer
G2 (GAPDH). The conditions of PCR amplification
were as follows: initial denaturation at 958 for 3 min,
each cycle of PCR including denaturation at 948 for 1
min, annealing at 608 for 2 min, and elongation at 728 for
3 min. Regular PCR was conducted in a similar manner,
except that annealing temperature, primers, and template
concentrations were routinely varied.
Quantitative RT-PCR
We constructed internal inhibitors according to
instructions in the Clontech kit. For VAMP-2, we cre-
ated elongated versions of Primers C and D that included
selected sequences of the MIMIC DNA fragment. PCR
using these modified primers and the MIMIC DNA as
a template produced an inhibitor fragment of approxi-
mately 650 bp. This fragment was then introduced in
known quantities into RT-PCR reactions for VAMP-2 in
which a 350-bp fragment would ordinarily be produced.
Increasing concentrations of the inhibitor decreased pro-
duction of the 350-bp fragment and increased production
of the 650-bp fragment. The intensities of the respective
bands, I for inhibitor and N for normal, were measured
as a function of inhibitor concentration C. A plot of the
log (N/ I) vs log (C) was linear and the x-intercept was
used to quantitate the nominal amount of VAMP-2 tem-
plate in the reactions.
Similar protocols were used for GAPDH. In this
cases, the inhibitor was constructed to be approximately
350 bp in length and was derived from primers G1 and
G2 (GAPDH). This inhibitor competed with a product
of greater length, namely, 774 bp for GAPDH.
Sequencing
Sequencing was conducted by Molecular Biology
Center for Research core facilities at Baylor College of
Medicine.
RESULTS
It has been reported that neutrophils express pro-
teins that are immunochemically related to syntaxin-1
(15), syntaxin-4, and VAMP-2 (16). Because promyelo-
cytic leukemia cell lines are commonly used as cultured
models for neutrophils, we wished to examine expres-
sion of these molecules in HL-60 cells. In so doing, we
also hoped to obtain sequence information concerning
the protein in myeloid cells.
Library Screens
VAMP-2
Using primers derived from the sequence of neu-
ronal VAMP-2, we used PCR to screen a differentiated
HL-60 cDNA library for related sequences. As a pos-
itive control, we used a library for human brain, from
which we could reasonably expect to obtain cDNA for
neuronal fusion proteins. Primer pairs A/ B and C/ D,
which covered most of the coding region, produced a
278-bp fragment from the pooled cDNA of the neuro-
nal library. Using primer pair C/ D, this neuronal frag-
ment was cloned into the EcoRI site of pBluescript.
The insert was sequenced and demonstrated to corre-
spond to human VAMP-2. Using primer pair C/ D, the
pooled cDNA of the differentiated HL-60 library was
screened with PCR—again, a 278 bp fragment (desig-
nated 1061B4B) was cloned and identified as VAMP-2
by sequencing. Thus, it appeared that the HL-60 library
contained cDNA for authentic VAMP-2.
In order to obtain the full length sequence for
this cDNA, we screened the library by standard plaque
techniques, using 300,000–1,000,000 plaque forming
units (pfu). We employed the partial coding sequence
1061B4B as our probe. We obtained a single clone
(designated M40D1), 848 bp long, containing an open
reading frame with the entire coding region for human
VAMP-2, with both 5′- and 3′-untranslated regions. This
sequence was identical to that published for the human
neuronal protein and contained portions of all five pub-
lished exons (24).
Syntaxin-4
In a similar manner, we screened several libraries
for sequences homologous to syntaxin-4. As a probe,
we employed an 820 nt segment of the 5′ coding region
of human muscle syntaxin-4, kindly provided by M. N.
Jagadish (22). Using high stringency, we were unable
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to detect any homologous sequences in HL-60 libraries
derived from either differentiated or undifferentiated
cells. However, a screen of a human “neutrophil” library
(derived from a mixture of activated leukocytes) yielded
a single partial sequence. This fragment starts at nt 411
in human muscle syntaxin-4 and contains the full 3′ end
of the authentic sequence. The 3′-untranslated region is
included, followed by a poly-A sequence.
Northern Blots
In order to determine the expression of these
sequences in mRNA, we differentiated HL-60 cells with
1.2% DMSO and withdrew samples at 1-day intervals
over a period of 4 days. RNA was isolated from cells at
each time point, separated by agarose gel electrophore-
sis in 1% formaldehyde, and blotted to nylon filters. Fil-
ters were probed with radiolabeled 1061B4B, the 278-
bp coding sequence for VAMP-2, and subsequently with
the 820 nt probe for syntaxin-4. As a positive control,
we used the coding sequence of p47phox, a component
of the phagocyte oxidase system that is expressed dur-
ing differentiation of HL-60 cells into the neutrophil lin-
eage. Finally, a 774 nt sequence of the coding region of
GAPDH was used to assess loading of the blots.
VAMP-2
Using either total RNA or mRNA purified by bind-
ing to poly-T-coated beads, we found that the VAMP-
2 probe consistently revealed a band at ∼1050 bp (not
shown). Another band, at ∼1.5 kb, was also found on
most blots of total and mRNA (not shown). Its abun-
dance paralleled the 1050-bp species and it may repre-
sent a precursor or alternatively spliced form. The size
of the 1050-bp band is consistent with that of our probe
and suggests that most of the sequence of the mRNA
is in hand. Northern blot analysis for VAMP-2 using
mRNA is shown in the upper part of Fig. 3. Relative
loading could be assessed either by blotting for GAPDH
or by the staining of the 28S ribosomal RNA bands (as
done in this experiment). In either case, the intensities
of the bands were measured and expressed as ratios of
VAMP-2 to GAPDH or rRNA. In all cases, the ratio
observed for HL-60 cells on Day 0 was arbitrarily set
at 1.0. As can be seen at the top of Fig. 1, expression of
VAMP-2 increased during differentiation of HL-60 cells
with DMSO. The ratio of VAMP-2 to 28S rRNA in this
experiment increased modestly on Days 1 and 2 and then
to threefold or greater on subsequent days.
Fig. 1. Northern Blot Analyses for VAMP-2 and p47phox. Total RNA
from HL-60 cells that were differentiated with 1.2% DMSO was
obtained over a period of 4 days. Poly-T-coated beads were used
to isolate mRNA from these samples. For the Northern blots, total
RNA (20 mg) or mRNA (4 mg) were subjected to electrophoresis on
1% formaldehyde gels. Molecular weight markers were provided by
28S and 18S rRNA. After electrophoresis, the RNA was transferred
to nylon filters and hybridized with probes for VAMP-2, p47phox, or
GAPDH. Total RNA probed for VAMP-2 is shown in the top panel and
was exposed for 3 days. The middle panel shows total RNA probed
for p47phox and was exposed for 1 day. Ribosomal RNA (28S) bands
were scanned and inverted in intensity (lower panel). The intensities
of each band were measured with ImageQuant software. The software
automatically subtracted background values from areas of the film sur-
rounding each identified band. These values were then expressed as
ratios of VAMP-2/ rRNA or p47phox/ rRNA, normalized to Day 0, and
are shown on the figure. See Materials and Methods for further details.
We used p47phox as a positive control for a pro-
tein that is upregulated during differentiation (21). As
expected, the p47phox probe hybridized strongly at 1.7
kb and increased from virtually nothing at Day 0 to
a maximum by Day 4. This pattern differed from
that for VAMP-2 in that p47phox was virtually unde-
tectable in undifferentiated cells, while some VAMP-2
was observed at all times.
The results from several Northern blots are com-
bined in Fig. 2. VAMP-2 was normalized with GAPDH
as well as 28S rRNA. It can be seen that on average,
the expression of VAMP-2 by HL-60 cells increased
threefold over the 4 days of the experiment. This was
observed when expressed as the VAMP-2/ rRNA ratio
(n c 4). In several experiments, the GAPDH/ rRNA
ratio also increased during differentiation (not shown).
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Fig. 2. Compilation of Northern Blot analyses for VAMP-2. Total
RNA was obtained from HL-60 cells as described previously and
probed for VAMP-2. The blots were stripped and then rehybridized
with a probe consisting of the coding region for GAPDH. Autora-
diograms were developed and signal intensities were measured as
described under Materials and Methods and in the legend to Fig. 1.
Intensities of the 28S rRNA bands were also measured. These val-
ues were then expressed as ratios of VAMP-2/ GAPDH or VAMP-
2/ 28S rRNA, normalized to Day 0 and are shown on the figure. The
data shown are the means (±SEM) compiled from five to six separate
experiments for VAMP-2/ GAPDH and four to five experiments for
VAMP-2/ 28S rRNA. The levels of significance (using a paired t test)
were calculated for differences from the Day 0 values (*, p < 0.05;
**, p < 0.01; ***, p < 0.002). See Materials and Methods for further
details.
As a consequence, the VAMP-2/ GAPDH ratio did not
increase in a statistically significant manner except on
Day 4.
Compared to HL-60 cells, both neutrophils and
monocytes had substantially higher expression of VAMP-
2. With expression by undifferentiated HL-60 cells being
defined as 1.0, the VAMP-2/ rRNA ratios were 6.1 ± 5.0
(n c 3) for neutrophils and 2.7 ± 1.7 (n c 3) for mono-
cytes; VAMP-2/ GAPDH ratios were 67 ± 21 (n c 6) for
neutrophils and 37 ± 21 (n c 6) for monocytes.
Syntaxin-4
In a similar manner, we studied the expression
of syntaxin-4 during the differentiation of HL-60 cells.
Using a probe derived from the coding region of human
muscle syntaxin-4, we found three bands to be present
during differentiation (Fig. 3). The strongest band was
found at ∼1.5 kb, a size consistent with the existence
of a 894 nt coding region. This band increased ∼50%
during differentiation (as a ratio with 28S rRNA). The
increase in GAPDH during differentiation meant that the
syntaxin-4/ GAPDH ratio was unchanged. Higher weight
transcripts at ∼3 kb were also found, suggesting that
Fig. 3. Northern Blot analysis for Syntaxin-4. Total RNA was obtained
from HL-60 cells as described previously. Neutrophils and monocytes
were also isolated from human blood and total RNA was extracted.
These samples were subjected to gel electrophoresis and Northern blot-
ting for syntaxin-4 (using an 820 nt section of the coding region as a
probe). The blots were stripped and then rehybridized with a probe
consisting of the coding region for GAPDH. The panels show the
Northern blots for syntaxin-4 (top), the inverted 28S rRNA bands
(middle), and the Northern blot for GAPDH (bottom). Signal inten-
sities were measured as described under Materials and Methods and
in the legend to Fig. 1. These values were then expressed as ratios
of syntaxin-4/ GAPDH or syntaxin-4/ 28S rRNA, normalized to Day 0
and are shown on the figure. See Materials and Methods for further
details.
some transcriptional regulation and processing or alter-
native splicing was occurring. The 1.5-kb bands were
also detected in RNA preparations from neutrophils and
monocytes (Fig. 3). The ratios of syntaxin-4/ GADPH
were substantially higher than for HL-60 cells (defined
as 1.0)—14.7 ± 5.6 (n c 5) for neutrophils and 14.3 ± 6.7
(n c 5) for monocytes. The syntaxin-4/ 28S rRNA ratios
for all three cell types were roughly comparable—0.95
± 0.34 (n c 3) for neutrophils and 1.5 ± 0.4 (n c 3) for
monocytes.
We performed Northern blot analysis in several sep-
arate experiments, the combined results of which are
shown in Fig. 4. A pattern similar to that for VAMP-
2 (Fig. 2) was found for syntaxin-4. On average, the
expression of syntaxin-4 by HL-60 cells, measured as
syntaxin-4/ 28S rRNA, increased by 50% over the 4 days
of the experiment (much less than the threefold increase
found to VAMP-2). This increase was statistically signif-
icant by Day 4. As before, concomitant increases in the
expression of GAPDH prevented the ratio of syntaxin-
4/ GAPDH from achieving a high level of significance.
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Fig. 4. Compilation of Northern Blot analysis for Syntaxin-4. Total
RNA was obtained from HL-60 cells as described previously and
probed for syntaxin-4. The blots were stripped and then rehybridized
with a probe consisting of the coding region for GAPDH. Autora-
diograms were developed and signal intensities were measured as
described under Materials and Methods and in the legend to Fig. 1.
Intensities of the 28S rRNA bands were also measured. These val-
ues were then expressed as ratios of syntaxin-4/ GAPDH or syntaxin-
4/ 28S rRNA, normalized to Day 0 and are shown on the figure. The
data shown are the means (±SEM) compiled from two to four separate
experiments for syntaxin-4/ GAPDH and two to three experiments for
syntaxin-4/ 28S rRNA. The levels of significance (using a one-tailed
Student t test) were calculated for increases in the ratios above 1.0.
For the syntaxin-4/ 28S rRNA ratio, the level at Day 4 was significantly
(p < 0.05) greater than that on Day 0. See Materials and Methods for
further details.
Quantitative RT-PCR
In order to get an independent measure of the level
of mRNA expression for VAMP-2 and syntaxin-4, we
performed quantitative RT-PCR. We first determined that
our selected primers for VAMP-2 and GAPDH (see
Methods) all produced RT-PCR products of the expected
size and sequence from the total RNA of HL-60 cells.
Using the MIMIC Construction Kit (Clontech), we pre-
pared “internal inhibitors” for VAMP-2 and GAPDH.
These internal inhibitors are sequences that have anneal-
ing sites for the primers, but are of distinctly differ-
ent sizes than the authentic PCR products. Hence, in
the PCR reaction, increasing amounts of the internal
inhibitor will compete with the authentic template for
primers, with both products being distinguishable fol-
lowing gel electrophoresis. Careful titration of the PCR
reactions with varying amounts of the internal inhibitors
permits quantitation of the amount of template in each
RT reaction.
The absolute abundances of VAMP-2 and GAPDH
RT products are shown in Table 1. The amount of
VAMP-2 template in the RT reactions was comparable
for HL-60 cells and neutrophils. However, monocytes
possessed several-fold more of this template per unit
of total RNA. For GAPDH transcripts, high abundances
were found for HL-60 cells, with low and comparable
quantities measured for neutrophils and monocytes. On
a cellular basis, all three cell types had similar amounts
of VAMP-2 template. For GAPDH, the amount of tem-
plate was by far the greatest in HL-60 cells.
RT-PCR confirmed some quantitative aspects of
the Northern blot data. First, that the quantity of
transcript for VAMP-2 increased during differentiation.
The amount of GAPDH transcript also increased, but to
a lesser extent (Table 1). These data also demonstrated
that monocyte contamination of the neutrophil prepara-
tions, generally found to be 5–10%, could not account
for the abundance of transcript in the neutrophils.
We also used quantitative RT-PCR as an indepen-
Table 1. mRNA Levels Determined by Quantitative RT-PCR
VAMP-2a VAMP-2b GAPDHa GAPDHb
Cell Type (per mg Total RNA) (per 106 cells) (per mg Total RNA) (per 106 cells)
HL-60 Day 0 2.6 ± 1.7 (6) 40.7 ± 20.7 (4) 23.5 ± 20.3 (6) 485 ± 303 (4)
HL-60 Day 4 11.9 ± 4.6 (5) 92.7 ± 81.7 (4) 32.3 ± 22.9 (5) 408 ± 365 (4)
Neutrophils 8.0 ± 4.2 (5) 15.9 ± 14.9 (3) 1.35 ± 0.50 (5) 1.24 ± 0.84 (3)
Monocytes 24.6 ± 8.4 (5) 25.2 ± 14.4 (3) 0.65 ± 3.0 (5) 0.53 ± 0.18 (3)
Note. Total RNA was extracted from unstimulated HL-60 cells, human neutrophils, and human
peripheral blood monocytes. Aliquots of total RNA (1 mg) were used for the reverse transcriptase
reaction as detailed under Materials and Methods. Levels of mRNA transcript were estimated by
titrating with internal inhibitors, devised using the MIMIC system (Clontech). The data are presented
as means ± SEM with number of experiments in parentheses.
a Attomoles/ mg Total RNA.
b Attomoles/ 106 cells.
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Fig. 5. Quantitative RT-PCR for VAMP-2 and GAPDH. Total RNA
was extracted from HL-60 cells that were stimulated with 1.2% DMSO
over a 4-day time course from human neutrophils and from human
peripheral blood monocytes. Aliquots of total RNA (1 mg) were used
for the reverse transcriptase reaction as detailed under Materials and
Methods. Levels of mRNA transcript were estimated by titrating
with internal inhibitors, devised using the MIMIC system (Clontech).
Expression of VAMP-2 was normalized with respect to GAPDH; the
ratio at Day 0 was defined as 1.0. Expression at different times are pre-
sented as means ±SEM (n c 4). The ratio at Day 1 was significantly
different from Day 0 control (*, 1-way ANOVA with Dunnett post-
test). The comparable ratios for neutrophils and monocytes were 35 +
27 and 193 ± 129, respectively (n c 5).
dent means to obtain VAMP-2/ GAPDH ratios. As can
be seen in Fig. 5, the ratio of VAMP-2 to GAPDH
increased during the differentiation of HL-60 cells. The
increase on Day 1 was statistically greater than the ratio
found on Day 1.
DISCUSSION
Degranulation is one of the most important re-
sponses of neutrophils in inflammation and bacterial
killing. Nonetheless, the prerequisite membrane fusion,
involving membrane events employed by a cell engaged
in endo- or exocytosis, has been difficult to model in the
laboratory and is consequently poorly understood. Sev-
eral recent advances, such as isolation of endogenous
fusogens and development of contents-mixing fusion
assays have permitted an investigation of membrane
fusion and secretion by human neutrophils (18, 19,
25–28). However, because of the attention paid to the
fusion complex associated with neuronal tissues and the
apparent ubiquity of many members of this fusion com-
plex in a variety of cell types (11, 13), we sought to
determine if such proteins were being produced in HL-
60 cells or neutrophils.
VAMP-2
Although previous studies reported immunochemi-
cal evidence for VAMP-2 protein in tertiary granules
and secretory granules in neutrophils (16), little is known
at the molecular level about the expression of VAMP-2
in myeloid cells. Following membrane fusion, VAMP-
2 appeared to translocate to the plasma membrane fol-
lowing stimulation. However, this work was limited to
assessing immunologically cross-reacting protein in neu-
trophils. Our studies reported here extend this earlier
work by (1) showing that HL-60 cells, as well as rest-
ing neutrophils and monocytes, produced mRNA for
VAMP-2; (2) that the abundance of VAMP-2 mRNA,
assessed by quantiative RT-PCR, was similar in all three
cell types when measured on a cellular basis; (3) that
the nucleotide, and hence the protein, sequences were
identical to those published for human VAMP-2; (4) the
mRNA for VAMP-2 was produced in both differentiated
and undifferentiated HL-60 cells; and (5) the mRNA for
VAMP-2 increased approximately threefold during dif-
ferentiation.
Screening a library constructed from the cDNA of
differentiated HL-60 cells for VAMP-2, we obtained a
single clone (termed M40D1). This sequence was 848
bp in length, containing an open reading frame, and
was identical (in the coding sequence) to that reported
for human VAMP-2, which is encoded in five exons
(24). Our 848-bp sequence had 28 bp of 5′-untranslated
sequence as well as 427 bp of 3′-untranslated sequence,
that was rich in poly-A. Northern blots of total RNA at
high stringency revealed a band of hybridization approx-
imately 1050 bp. This length corresponds relatively well
to the size of M40D1 and indicates that most of the
VAMP-2 mRNA in the HL-60 cells is represented in
M40D1. This cDNA covers more of the 3′ end of the
published sequence (24) than it does of the 5′ end. Using
M40D1 as a frame of reference, exon 1 of the published
sequence covers from −919 to 37, with the ORF start-
ing at bp 29. The remaining exons are relatively short.
Exon 2 covers bp 5–158, exon 3 covers 129–317, exon
4 covers 290–368, and exon 5 covers 336–485. Except
for the overlap regions between the exons, which con-
tain sequence variability at the splicing sites, the pub-
lished sequence is identical to that of M40D1 over the
common 485-bp region.
The fidelity of the 3′ region of M40D1 can be illu-
minated by a published sequence of rat VAMP-2 (29)
that is 2071 bp long. This sequence has 86% identity
in the common overlap region and is almost completely
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identical from bp 21 to 600. Between 600 and 848,
the two sequences deviate substantially. Hence, M40D1
has virtual identity to published sequences, both within
the coding regions and over mesial stretches of the 3′-
untranslated end.
Our Northern blots using total RNA or isolated
mRNA often showed an additional band at ∼1.5 kb, sug-
gesting that alternative splicing or processing is taking
place at the mRNA level. Indeed, it appears that the
abundance of mRNA increased three- to fourfold during
the differentiation of HL-60 cells as measured by sev-
eral different criteria. This was confirmed by Northern
blot analysis (VAMP-2/ 28S rRNA ratios) and quantita-
tive RT-PCR. It should be noted that the tedious nature
of quantitative RT-PCR precluded the routine use of the
technique.
A somewhat different trend was observed with
p47phox, our positive control. As expected (21), p47phox
mRNA was virtually undetectable in undifferentiated
HL-60 cells (in spite of the high loading of this lane) and
increased rapidly during differentiation (Fig. 1). Hence,
it appeared that VAMP-2 mRNA increased modestly
during differentiation, while p47phox increased dramati-
cally. Nevertheless, these increases in mRNA occur at
a time when HL-60 cells become more competent with
respect to both superoxide generation and degranulation.
It is likely that enhanced transcription of VAMP-2 helps
support degranulation in the differentiated cells.
We are also the first to measure of absolute abun-
dances of mRNA, using quantitative RT-PCR, in these
three cell types. On a cellular basis, HL-60 cells, neu-
trophils, and monocytes all had comparable amounts of
transcript (Table 1). In contrast, HL-60 cells had far
more transcript for GAPDH than did monocytes or neu-
trophils (Table 1). One possible explanation is that HL-
60 cells in culture are actively undergoing proliferation
and differentiation, requiring higher expression of house-
keeping genes. Furthermore, neutrophils are notoriously
deficient in both RNA (30) and protein (31, 32) syn-
thesis, consistent with the relatively low levels found
in Table 1. Indeed, we had previously noted that HL-
60 cells were a particularly abundant source of GAPDH
protein when we were isolating it as an endogenous fuso-
gen (33).
The RT-PCR product from the RNA of human neu-
trophils had a sequence identical to that of HL-60 cells
(not shown). This was gratifying since differentiated HL-
60 cells are not identical to neutrophils, the two cells
types differing in many details of biochemistry, cell biol-
ogy, and function (34–36). Whereas the array of proteins
actively synthesized by neutrophils is quite limited, our
data from RT-PCR indicate that VAMP-2 is a member
of this highly selective group of proteins. Such specu-
lations are consistent with the possibility that VAMP-2
is an essential component of the degranulation apparatus
that must be expressed in greater abundance as the cells
become more competent in degranulation.
Syntaxin-4
Syntaxin-4 was originally detected in neutrophils by
means of immunoblotting (16). Recently, Martin-Mar-
tin et al. used RT-PCR to detect expression of syntaxins
1A, 3, 4, 5, 6, 7, 9, 11, and 16 in neutrophils and HL-
60 cells (15). They also reported that expression of syn-
taxins 3, 4, 6, and 11 increased during differentiation of
HL-60 cells. Our studies extend this work by showing
that (1) monocytes, in addition to HL-60 cells and neu-
trophils, express mRNA highly homologous to syntaxin-
4 when examined by Northern blot; (2) Northern blot
analysis confirms that a ∼1.5 kb transcript, consistent
in size with the 894 nt coding region of syntaxin-4,
is increased during differentiation of HL-60 cells; (3)
additional sequence information has been provided by
screening a human neutrophil library.
As shown in Figs. 3 and 4, differentiation increased
expression of syntaxin-4 approximately 50% in HL-60
cells. These findings are consistent with the possibility
that enhanced synthesis of syntaxin-4 is, like VAMP-2,
necessary for increased degranulation in mature HL-60
cells. However, this increase is far more modest than
that for VAMP-2. It is possible that syntaxin-4 is nor-
mally produced in surplus even in undifferentiated cells.
These data are also comparable to the observations of
Martin-Martin et al. (15), although this group did not
quantitate their findings. Our findings of comparable
monocyte expression, but considerably lower neutrophil
expression, were also observed by Martin-Martin et al.
(15). However, because 28S rRNA or GAPDH are rela-
tively scarce in neutrophils, the ratios of syntaxin-4/ 28S
rRNA or syntaxin-4/ GAPDH were comparable to those
of monocytes (Fig. 3).
We obtained sequence information complementary
to that of Martin-Martin et al. (15), who reported only
the coding region. Our partial sequence, derived from
a human neutrophil library, starts at nt 411, continues
into the 3′-untranslated region and is followed by a
poly-A sequence. This fragment begins downstream of
a reported splice point containing an intron of 136 nt
(15), that we consequently could not detect. Combining
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our sequence information with that of Martin-Martin et
al. (15) and including the 136 nt intron, we would expect
a length of almost 1.3 kb. The 5′-untranslated region is
unknown, but is likely to be no more than a few hun-
dred base pairs. Hence, the putative transcript is con-
sistent with the ∼1.5 kb band that we observed in Fig.
5. It should be noted that longer transcripts were also
observed in differentiating HL-60 cells (Fig. 3), suggest-
ing additional processing of mRNA. It is also important
to note that the neutrophil library did contain contami-
nants from other cell types (see Materials and Methods).
Hence, it is possible that this complementary sequence
information is not attributable to neutrophils.
Speculations—A Nontraditional Fusion Apparatus
for Neutrophils?
It has recently been reported tha the full set of
SNARE proteins is not necessary for docking and fusion
of membranes. Rather, only VAMP-2 syntaxin-1A, and
SNAP-25 are sufficient for docking and low-rate fusion
(37–39). It is likely that such low-rate fusion could be
greatly accelerated by other cofactors, such as phospho-
lipases or annexins. These latter proteins are abundant in
neutrophils and are activated following cell stimulation.
There is increasing evidence that the fusion pro-
teins operating in cells of the myeloid lineage are sub-
stantially different from those in neurons. For exam-
ple, VAMP-2, syntaxin-4, and secretory carrier mem-
brane protein (SCAMP) were detected in neutrophils
by Western blot (16). These investigators also reported
that they were unable to find the classical neuronal
components syntaxin-1, VAMP-1, SNAP-25, synapto-
physin, and cellubrevin. Another research group did find
SNAP-25 protein, but it was on the “wrong” vesicle
(granule membrane rather than plasma membrane) (14).
Human neutrophils and HL-60 cells have been reported
to have two forms of SNAP-23 (17), based on molecular
studies. SNAP-23 is non-neuronal and these researchers
found that mRNA for this protein increased during dif-
ferentiation of HL-60 cells. Interestingly, those compo-
nents that have been detected in neutrophils and HL-60
cells, namely, VAMP-2, multiple syntaxins, and SNAP-
23 (25), are homologues of the SNAREpin set (37).
It is possible that many cell types feature subsets of
the neuronal system, along with other components, some
of which might be unique. Neutrophils, for example,
might have only VAMP-2 on the granule membranes
as a direct representative on the neuronal complement.
Myeloid cells have multiple forms of syntaxin (15) cor-
responding to SNAREpin syntaxin-1, although syntaxin-
1 itself is found on the wrong (granule) membrane.
The other neuronal components of the SNARE complex
appear to be absent. The roles of these missing compo-
nents might be played by other proteins known to induce
fusion in neutrophils. For example, we have demon-
strated that annexin I (18) and GAPDH (19) are cytoso-
lic fusogens in neutrophils. We have also shown that
phospholipase D, in conjunction with annexin I, is capa-
ble of promoting the aggregation of granules and arti-
ficial membranes (27). Finally, phospholipase A2 that is
activated in stimulated neutrophils (40–44) is exquisitely
sensitive in promoting fusion (26). We expect that cells
of the granulocytic lineage will have a set of fusion pro-
teins that has both commonality with some elements of
the neuronal complement, as well as uniqueness.
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